Lineage Cell Therapeutics, Inc.

The current price of LCTX is 1.10 USD — it has decreased by 3.51% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Lineage Cell Therapeutics, Inc. stocks are traded under the ticker LCTX.

Lineage Cell Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

LCTX stock is 4.55% volatile and has beta coefficient of 0.48. Check out the list of the most volatile stocks — is Lineage Cell Therapeutics, Inc. there?

LCTX earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.04 USD resulting in a 4.00% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Lineage Cell Therapeutics, Inc. earnings.

Lineage Cell Therapeutics, Inc. revenue for the last quarter amounts to ‪1.25 M‬ USD despite the estimated figure of ‪2.60 M‬ USD. In the next quarter revenue is expected to reach ‪2.64 M‬ USD.

Yes, you can track Lineage Cell Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

LCTX stock has fallen by 5.17% compared to the previous week, the month change is a 12.00% fall, over the last year Lineage Cell Therapeutics, Inc. has showed a 19.12% decrease.

Today Lineage Cell Therapeutics, Inc. has the market capitalization of ‪214.93 M‬, it has decreased by 0.87% over the last week.

No, LCTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, LCTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lineage Cell Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

LCTX reached its all-time high on Oct 31, 1997 with the price of 24.94 USD, and its all-time low was 0.09 USD and was reached on Nov 7, 2005.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 75.00 employees. See our rating of the largest employees — is Lineage Cell Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lineage Cell Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lineage Cell Therapeutics, Inc. stock shows the strong sell signal. See more of Lineage Cell Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Lineage Cell Therapeutics, Inc. future price: according to them, LCTX price has a max estimate of 7.00 USD and a min estimate of 4.00 USD. Read a more detailed Lineage Cell Therapeutics, Inc. forecast: see what analysts think of Lineage Cell Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lineage Cell Therapeutics, Inc. EBITDA is ‪−24.04 M‬ USD, and current EBITDA margin is −268.76%. See more stats in Lineage Cell Therapeutics, Inc. financial statements.